Success Metrics

Clinical Success Rate
66.7%

Based on 2 completed trials

Completion Rate
67%(2/3)
Active Trials
1(25%)
Results Posted
50%(1 trials)
Terminated
1(25%)

Phase Distribution

Ph phase_3
1
25%
Ph not_applicable
3
75%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution4 total trials
Phase 3Large-scale testing
1(25.0%)
N/ANon-phased studies
3(75.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

66.7%

2 of 3 finished

Non-Completion Rate

33.3%

1 ended early

Currently Active

1

trials recruiting

Total Trials

4

all time

Status Distribution
Active(1)
Completed(2)
Terminated(1)

Detailed Status

Completed2
Active, not recruiting1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
1
Success Rate
66.7%
Most Advanced
Phase 3

Trials by Phase

Phase 31 (25.0%)
N/A3 (75.0%)

Trials by Status

active_not_recruiting125%
completed250%
terminated125%

Recent Activity

1 active trials
Showing 4 of 4
active_not_recruitingnot_applicable

The Counselor Led Resident Wellness Study

NCT07053111
completednot_applicable

Novel Interventions for GWVI

NCT02661997
terminatednot_applicable

3-month Aerobic and Resistance Exercise Intervention for Individuals Diagnosed With Melanoma

NCT03825913
completedphase_3

Maximizing Treatment Outcome and Examining Sleep in Post-traumatic Stress Disorder (PTSD)

NCT01199107

Clinical Trials (4)

Showing 4 of 4 trials
NCT07053111Not Applicable

The Counselor Led Resident Wellness Study

Active Not Recruiting
NCT02661997Not Applicable

Novel Interventions for GWVI

Completed
NCT03825913Not Applicable

3-month Aerobic and Resistance Exercise Intervention for Individuals Diagnosed With Melanoma

Terminated
NCT01199107Phase 3

Maximizing Treatment Outcome and Examining Sleep in Post-traumatic Stress Disorder (PTSD)

Completed

All 4 trials loaded

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
4